News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
ABO Energy: Bondholders support restructuring
ABO Energy bondholders support company restructuring with over 99% majority votes, allowing provision of collateral for tariff tenders. Waiver of termination rights ensures ongoing restructuring progress. Joint representative appointed for negotiations -
-
-
COMMUNIQUÉ DE PRESSE
Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease
Skyhawk Therapeutics appoints Aaron Deves as Chief Commercial Officer to drive SKY-0515 launch for Huntington's Disease. Deves brings extensive experience in launching therapies for neurological diseases -
